EGFR Boltbody

N/A

Report date: 2025/03/20 14:52:49

Base Information

Drug NameEGFR Boltbody
Drug Alias Namedendritic cell-activating anti-EGFR antibody (Bolt Biotherapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck NeoplasmsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBolt Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBolt Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A